Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters










Publication year range
1.
PLoS One ; 13(7): e0200236, 2018.
Article in English | MEDLINE | ID: mdl-29979752

ABSTRACT

BACKGROUND: Many studies investigating the impact of individual risk factors on cord blood immune cell counts may be biased given that cord blood composition is influenced by a multitude of factors. The aim of this study was to comprehensively investigate the relative impact of environmental, hereditary and perinatal factors on cord blood cells. METHODS: In 295 neonates from the prospective Basel-Bern Infant Lung Development Cohort, we performed complete blood counts and fluorescence-activated cell sorting scans of umbilical cord blood. The associations between risk factors and cord blood cells were assessed using multivariable linear regressions. RESULTS: The multivariable regression analysis showed that an increase per 10µg/m3 of the average nitrogen dioxide 14 days before birth was associated with a decrease in leukocyte (6.7%, 95% CI:-12.1,-1.0) and monocyte counts (11.6%, 95% CI:-19.6,-2.8). Maternal smoking during pregnancy was associated with significantly lower cord blood cell counts in multiple cell populations. Moreover, we observed sex differences regarding eosinophilic granulocytes and plasmacytoid dendritic cells. Finally, significantly increased numbers of cord blood cells were observed in infants exposed to perinatal stress. Cesarean section seems to play a significant role in Th1/Th2 balance. CONCLUSIONS: Our results suggest that all three: environmental, hereditary and perinatal factors play a significant role in the composition of cord blood cells at birth, and it is important to adjust for all of these factors in cord blood studies. In particular, perinatal circumstances seem to influence immune balance, which could have far reaching consequences in the development of immune mediated diseases.


Subject(s)
Fetal Blood/cytology , Prenatal Exposure Delayed Effects , Sex Characteristics , Smoking , Female , Flow Cytometry , Gestational Age , Humans , Infant, Newborn , Leukocyte Count , Leukocytes , Male , Pregnancy , Prospective Studies , Risk Factors
2.
Cell Death Dis ; 9(5): 510, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29724998

ABSTRACT

Binding of allergen-specific IgE to its primary receptor FcεRI on basophils and mast cells represents a central event in the development of allergic diseases. The high-affinity interaction between IgE and FcεRI results in permanent sensitization of these allergic effector cells and critically regulates their release of pro-inflammatory mediators upon IgE cross-linking by allergens. In addition, binding of monomeric IgE has been reported to actively regulate FcεRI surface levels and promote survival of mast cells in the absence of allergen through the induction of autocrine cytokine secretion including interleukin-3 (IL-3). As basophils and mast cells share many biological commonalities we sought to assess the role of monomeric IgE binding and IL-3 signaling in FcεRI regulation and cell survival of primary human basophils. FcεRI cell surface levels and survival of isolated blood basophils were assessed upon addition of monomeric IgE or physiologic removal of endogenous cell-bound IgE with a disruptive IgE inhibitor by flow cytometry. We further determined basophil cell numbers in both low and high serum IgE blood donors and mice that are either sufficient or deficient for FcεRI. Ultimately, we investigated the effect of IL-3 on basophil surface FcεRI levels by protein and gene expression analysis. Surface levels of FcεRI were passively stabilized but not actively upregulated in the presence of monomeric IgE. In contrast to previous observations with mast cells, monomeric IgE binding did not enhance basophil survival. Interestingly, we found that IL-3 transcriptionally regulates surface levels of FcεRI in human primary basophils. Our data suggest that IL-3 but not monomeric IgE regulates FcεRI expression and cell survival in primary human basophils. Thus, blocking of IL-3 signaling in allergic effector cells might represent an interesting approach to diminish surface FcεRI levels and to prevent prolonged cell survival in allergic inflammation.


Subject(s)
Basophils/immunology , Hypersensitivity/genetics , Immunoglobulin E/genetics , Interleukin-3/genetics , Receptors, IgE/genetics , Animals , Basophils/drug effects , Basophils/pathology , Cell Survival/drug effects , Gene Expression Regulation , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , Hypersensitivity/immunology , Hypersensitivity/physiopathology , Immunoglobulin E/immunology , Interleukin-3/immunology , Interleukin-3/pharmacology , Interleukin-5/genetics , Interleukin-5/immunology , Interleukin-5/pharmacology , Mast Cells/immunology , Mast Cells/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Primary Cell Culture , Receptors, IgE/deficiency , Receptors, IgE/immunology , Signal Transduction , Transcription, Genetic
3.
J Leukoc Biol ; 101(1): 227-238, 2017 01.
Article in English | MEDLINE | ID: mdl-27443880

ABSTRACT

Cytokines of the GM-CSF family signal via the same receptor subunit (ßc) and, thus, have overlapping effects on cells that express all cytokine-specific α-chains (IL-3Rα, IL-5Rα, GM-CSFRα), such as human basophils, whose rapid effector functions are similarly enhanced by IL-3, IL-5, and GM-CSF. However, previous work has shown that IL-3, but not IL-5 and GM-CSF, supports and induces allergy-associated functions of human basophils at later time points. This includes induction of Th2 cytokine and chemokine secretion, high-affinity IgE receptor-independent leukotriene C4 (LTC4) formation, expression of enzymes (e.g., RALDH2, granzyme B), and kinases (e.g., Pim1). Here, we address the question of why IL-3, but not IL-5 or GM-CSF, is capable of inducing these late responses in human basophils, and we investigate the mechanism that underlies the unique regulatory capacity of IL-3. We find that IL-3, IL-5, and GM-CSF rapidly activate the same canonical signaling cascades in a qualitatively identical manner with comparable strength, but we identify signaling duration as major discriminating factor. IL-5 and GM-CSF rapidly down-regulate surface levels of their receptors within minutes, concomitant with a rapid decay in signaling molecule activation and time-dependent loss of ability of these cytokines to prime basophils for functional responses. By contrast, IL-3 hardly down-regulates the α-chain of its receptor without depleting the common ß-chain, which enables extraordinarily sustained signaling events, predominantly the activation of Stat5. Of interest, acute IL-3 signaling is not sufficient to induce persistent phenotypical and functional changes in human basophils. Induction of these functional late responses depends on continuous IL-3 receptor activation and signaling.


Subject(s)
Basophils/metabolism , Interleukin-3/metabolism , Receptors, Interleukin-3/metabolism , Signal Transduction , Down-Regulation/drug effects , Eosinophils/drug effects , Eosinophils/metabolism , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , Interleukin-5/metabolism , Kinetics , Ligands , Phenotype , Phosphorylation/drug effects , STAT5 Transcription Factor/metabolism , Signal Transduction/drug effects
4.
Methods Mol Biol ; 1192: 87-100, 2014.
Article in English | MEDLINE | ID: mdl-25149486

ABSTRACT

The absolute basophil count (cells/L) can be determined by manual counting of peripheral blood smears or using cell-counting chambers as well as by automated hematology analyzers and fluorescence flow cytometry. Manual basophil counting of peripheral blood smears is currently regarded as the reference method, although the limitations of this method (distribution, observer, and statistical errors) are widely recognized. Automated hematology analyzers offer an advantage of larger numbers of counted cells and high throughput but are characterized by inconsistent analytical performance for basophil enumeration. Flow cytometric enumeration of circulating basophils using panels of monoclonal antibodies is being developed as novel candidate reference method for the absolute basophil count in peripheral blood. Basophil counting using fluorescence flow cytometry is characterized by high precision and statistical superiority. Emerging innovative technologies for absolute cell counts include ImageStream technology and on-chip blood counting but their analytical performance for absolute basophil counts is yet to be established. Here, we describe various techniques for absolute basophil counting in peripheral blood including manual basophil counts in smears and hemocytometers and flow-cytometric methodologies using double-platform, bead-based, and volumetric approaches.


Subject(s)
Basophils/cytology , Animals , Flow Cytometry/methods , Flow Cytometry/standards , Humans , Leukocyte Count/methods , Leukocyte Count/standards , Microspheres , Staining and Labeling
5.
J Allergy Clin Immunol ; 133(6): 1709-19.e8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24642143

ABSTRACT

BACKGROUND: The remarkably stable interaction of IgE with its high-affinity receptor FcεRI on basophils and mast cells is critical for the induction of allergic hypersensitivity reactions. Because of the exceptionally slow dissociation rate of IgE-FcεRI complexes, such allergic effector cells permanently display allergen-specific IgE on their surface and immediately respond to allergen challenge by releasing inflammatory mediators. We have recently described a novel macromolecular inhibitor that actively promotes the dissociation of IgE from FcεRI through a molecular mechanism termed facilitated dissociation. OBJECTIVE: Here we assessed the therapeutic potential of this non-immunoglobulin-based IgE inhibitor E2_79, a designed ankyrin repeat protein (DARPin), as well as a novel engineered biparatopic DARPin bi53_79, and directly compared them with the established anti-IgE antibody omalizumab. METHODS: IgE-FcεRI complex dissociation was analyzed in vitro by using recombinant proteins in ELISA and surface plasmon resonance, ex vivo by using human primary basophils with flow cytometry, and in vivo by using human FcεRI α-chain transgenic mice in a functional passive cutaneous anaphylaxis test. RESULTS: We show that E2_79-mediated removal of IgE from primary human basophils fully abrogates IgE-dependent cell activation and release of proinflammatory mediators ex vivo. Furthermore, we report that omalizumab also accelerates the dissociation of IgE from FcεRI, although much less efficiently than E2_79. Using the biparatopic IgE targeting approach, we further improved the disruptive potency of E2_79 by approximately 100-fold and show that disruptive IgE inhibitors efficiently prevent passive cutaneous anaphylaxis in mice expressing the human FcεRI α-chain. CONCLUSION: Our findings highlight the potential of such novel IgE inhibitors as important diagnostic and therapeutic tools for management of allergic diseases.


Subject(s)
Ankyrin Repeat , Immunoglobulin E/metabolism , Receptors, IgE/metabolism , Recombinant Fusion Proteins/pharmacology , Anaphylaxis/genetics , Anaphylaxis/immunology , Anaphylaxis/prevention & control , Animals , Antibodies, Anti-Idiotypic/administration & dosage , Antibodies, Anti-Idiotypic/chemistry , Antibodies, Anti-Idiotypic/pharmacology , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/chemistry , Antibodies, Monoclonal, Humanized/pharmacology , Antigens/immunology , Basophils/immunology , Basophils/metabolism , Dose-Response Relationship, Drug , Humans , Immunoglobulin E/chemistry , Mast Cells/immunology , Mast Cells/metabolism , Mice , Mice, Transgenic , Models, Molecular , Molecular Mimicry , Omalizumab , Protein Binding/drug effects , Protein Conformation , Receptors, IgE/chemistry , Receptors, IgE/genetics , Recombinant Fusion Proteins/administration & dosage , Recombinant Fusion Proteins/chemistry
6.
Curr Pharm Biotechnol ; 13(7): 1196-206, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21740372

ABSTRACT

Surgical repair of the rotator cuff repair is one of the most common procedures in orthopedic surgery. Despite it being the focus of much research, the physiological tendon-bone insertion is not recreated following repair and there is an anatomic non-healing rate of up to 94%. During the healing phase, several growth factors are upregulated that induce cellular proliferation and matrix deposition. Subsequently, this provisional matrix is replaced by the definitive matrix. Leukocyte- and platelet-rich fibrin (L-PRF) contain growth factors and has a stable dense fibrin matrix. Therefore, use of LPRF in rotator cuff repair is theoretically attractive. The aim of the present study was to determine 1) the optimal protocol to achieve the highest leukocyte content; 2) whether L-PRF releases growth factors in a sustained manner over 28 days; 3) whether standard/gelatinous or dry/compressed matrix preparation methods result in higher growth factor concentrations. 1) The standard L-PRF centrifugation protocol with 400 x g showed the highest concentration of platelets and leukocytes. 2) The L-PRF clots cultured in medium showed a continuous slow release with an increase in the absolute release of growth factors TGF-ß1, VEGF and MPO in the first 7 days, and for IGF1, PDGF-AB and platelet activity (PF4=CXCL4) in the first 8 hours, followed by a decrease to close to zero at 28 days. Significantly higher levels of growth factor were expressed relative to the control values of normal blood at each culture time point. 3) Except for MPO and the TGFß-1, there was always a tendency towards higher release of growth factors (i.e., CXCL4, IGF-1, PDGF-AB, and VEGF) in the standard/gelatinous- compared to the dry/compressed group. L-PRF in its optimal standard/gelatinous-type matrix can store and deliver locally specific healing growth factors for up to 28 days and may be a useful adjunct in rotator cuff repair.


Subject(s)
Blood Platelets/physiology , Fibrin/metabolism , Intercellular Signaling Peptides and Proteins/blood , Leukocytes/physiology , Rotator Cuff Injuries , Blood Platelets/metabolism , Fibrin/administration & dosage , Humans , Leukocytes/metabolism , Rotator Cuff/metabolism , Wound Healing/physiology
7.
J Allergy Clin Immunol ; 128(6): 1227-1234.e5, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21855127

ABSTRACT

BACKGROUND: The in vivo autologous serum skin test (ASST) is the diagnostic gold standard to detect autoantibodies against FcεRI or IgE itself, as well as other autoreactive serum components, in patients with chronic spontaneous urticaria (CU). Coincubation of patient sera with donor basophils and measuring their degranulation in vitro could be a safe alternative but has shown inconsistent results. OBJECTIVE: Optimization of the basophil activation test to detect autoreactive serum components in patients with CU. METHODS: The ability of patient sera to induce CD63 and CD203c in donor basophils (n = 15) was measured by means of flow cytometry. Sera of 20 patients with CU (10 with positive ASST results), 15 patients with cold urticaria, and 27 healthy control subjects were included to optimize test conditions with donor basophils and a basophil cell line (RBL703/21) followed by testing of 110 consecutive patients from clinical routine. RESULTS: We demonstrate that individual IL-3 priming normalized the initially inconsistent basophil reactivity and led to reproducible and comparable test results irrespective of the basophil donors used. CD203c as an activation marker and the use of a basophil cell line were less suitable for this purpose. CONCLUSION: The basophil activation test with individualized IL-3 priming for each basophil donor is a reproducible and reliable alternative to the ASST. There are several advantages over the ASST: no risk of accidental infection, no influence of antihistamines on the test result, quantifiable results, and a potential in providing treatment monitoring. The exact nature of the degranulating factor or factors in patient sera remains an open question.


Subject(s)
Basophil Degranulation Test/methods , Basophils/immunology , Interleukin-3/immunology , Urticaria/diagnosis , Adolescent , Adult , Aged , Basophils/metabolism , Cell Separation , Chronic Disease , Female , Flow Cytometry , Humans , Interleukin-3/metabolism , Male , Middle Aged , Urticaria/immunology , Young Adult
8.
Curr Opin Hematol ; 17(1): 60-6, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19741522

ABSTRACT

PURPOSE OF REVIEW: It is well appreciated that differentiation, growth, and function of basophils are regulated by a network of cytokines, and that these cells express a unique composition of surface receptors including interleukin-binding sites. In the current article, most recent discoveries around cytokine regulation of basophils are discussed and compared with previous data. RECENT FINDINGS: Confirming previous studies, the most potent growth factor for basophils remains interleukin (IL)-3, followed by granulocyte-macrophage colony-stimulating factor and IL-5. These cytokines also act on mature basophils through specific receptors, thereby mediating adhesion, migration, and releasability. Other molecules regulating basophil function are chemokines such as IL-8 or eotaxin and IL-33. Especially IL-33 has been described as a novel basophil regulator. All cytokines act on basophils via specific receptors and signal transduction pathways. The present article provides a summary of our knowledge on cytokine regulation of basophils and receptor expression, with emphasis on most recent developments in the field. SUMMARY: Basophil regulation by cytokines in health and disease may be a more complex process than has been considered previously. Some of the affected cytokine cascades, receptors, and signal transduction molecules may serve as targets of therapy in 'basophil activation disorders' in the future.


Subject(s)
Basophils/immunology , Interleukins/physiology , Myeloid Progenitor Cells/immunology , Animals , Basophils/cytology , Cell Adhesion , Cell Movement , Humans , Myeloid Progenitor Cells/cytology
9.
Exp Mol Pathol ; 87(2): 127-32, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19631640

ABSTRACT

Eotaxin/CCL11 chemokine is expressed in different organs, including the heart, but its precise cellular origin in the heart is unknown. Eotaxin is associated with Th2-like responses and exerts its chemotactic effect through the chemokine receptor-3 (CCR3), which is also expressed on mast cells (MC). The aim of our study was to find the cellular origin of eotaxin in the heart, and to assess whether expression is changing during ongoing acute heart transplant rejection, indicating a correlation with mast cell infiltration which we observed in a previous study. In a model of ongoing acute heart transplant rejection in the rat, we found eotaxin mRNA expression within infiltrating macrophages, but not in mast cells, by in situ-hybridization. A five-fold increase in eotaxin protein in rat heart transplants during ongoing acute rejection was measured on day 28 after transplantation, compared to native and isogeneic control hearts. Eotaxin concentrations in donor hearts on day 28 after transplantation were significantly higher compared to recipient hearts, corroborating an origin of eotaxin from cells within the heart, and not from the blood. The quantitative comparison of eotaxin mRNA expression between native hearts, isografts, and allografts, respectively, revealed no statistically significant difference after transplantation, probably due to an overall increase in the housekeeping gene's 18S rRNA during rejection. Quantitative RT-PCR showed an increase in mRNA expression of CCR3, the receptor for eotaxin, during ongoing acute rejection of rat heart allografts. Although a correlation between increasing eotaxin expression by macrophages and mast cell infiltration is suggestive, functional studies will elucidate the role of eotaxin in the process of ongoing acute heart transplant rejection.


Subject(s)
Chemokine CCL11/biosynthesis , Graft Rejection/immunology , Heart Transplantation/immunology , Macrophages/immunology , Animals , Enzyme-Linked Immunosorbent Assay , Graft Rejection/metabolism , Graft Rejection/pathology , Heart Transplantation/pathology , In Situ Hybridization , Macrophages/metabolism , Male , Mast Cells/immunology , RNA, Messenger/analysis , Rats , Rats, Inbred Lew , Reverse Transcriptase Polymerase Chain Reaction
10.
Arthritis Res Ther ; 11(3): R62, 2009.
Article in English | MEDLINE | ID: mdl-19419560

ABSTRACT

INTRODUCTION: Reconstitution of peripheral blood (PB) B cells after therapeutic depletion with the chimeric anti-CD20 antibody rituximab (RTX) mimics lymphatic ontogeny. In this situation, the repletion kinetics and migratory properties of distinct developmental B-cell stages and their correlation to disease activity might facilitate our understanding of innate and adaptive B-cell functions in rheumatoid arthritis (RA). METHODS: Thirty-five 'RTX-naïve' RA patients with active arthritis were treated after failure of tumour necrosis factor blockade in an open-label study with two infusions of 1,000 mg RTX. Prednisone dose was tapered according to clinical improvement from a median of 10 mg at baseline to 5 mg at 9 and 12 months. Conventional disease-modifying antirheumatic drugs were kept stable. Subsets of CD19+ B cells were assessed by flow cytometry according to their IgD and CD27 surface expression. Their absolute number and relative frequency in PB were followed every 3 months and were determined in parallel in synovial tissue (n = 3) or synovial fluid (n = 3) in the case of florid arthritis. RESULTS: Six of 35 patients fulfilled the European League Against Rheumatism criteria for moderate clinical response, and 19 others for good clinical response. All PB B-cell fractions decreased significantly in number (P < 0.001) after the first infusion. Disease activity developed independently of the total B-cell number. B-cell repopulation was dominated in quantity by CD27-IgD+ 'naïve' B cells. The low number of CD27+IgD- class-switched memory B cells (MemB) in the blood, together with sustained reduction of rheumatoid factor serum concentrations, correlated with good clinical response. Class-switched MemB were found accumulated in flaring joints. CONCLUSIONS: The present data support the hypothesis that control of adaptive immune processes involving germinal centre-derived, antigen, and T-cell-dependently matured B cells is essential for successful RTX treatment.


Subject(s)
Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/therapy , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Immunoglobulin Class Switching/immunology , Immunoglobulins/classification , Lymphocyte Depletion , B-Lymphocytes/classification , Cell Count/methods , Cell Separation/methods , Female , Flow Cytometry/methods , Humans , Immunoglobulins/biosynthesis , Male , Middle Aged , Prospective Studies
11.
J Immunol ; 182(10): 6527-32, 2009 May 15.
Article in English | MEDLINE | ID: mdl-19414807

ABSTRACT

Leukotriene B(4) (LTB(4)) is an important proinflammatory lipid mediator generated by neutrophils upon activation. GM-CSF stimulation is known to enhance agonist-mediated LTB(4) production of neutrophils within minutes, a process called "priming". In this study, we demonstrate that GM-CSF also limits the production of LTB(4) by neutrophils via a transcriptional mechanism at later time points. We identified hemopoietic-specific Ras homologous (RhoH)/translocation three four (TTF), which was induced following GM-CSF stimulation in neutrophils, as a key regulator in this process. Neutrophils derived from RhoH/TTF-deficient (Rhoh(-/-)) mice demonstrated increased LTB(4) production upon activation compared with normal mouse neutrophils. Moreover, neutrophils from cystic fibrosis patients expressed enhanced levels of RhoH/TTF and generated less LTB(4) upon activation compared with normal human neutrophils. Taken together, these data suggest that RhoH/TTF represents an inducible feedback inhibitor in neutrophils that is involved in the limitation of innate immune responses.


Subject(s)
Cystic Fibrosis/immunology , Gene Expression Regulation/immunology , Leukotriene B4/biosynthesis , Neutrophils/metabolism , Transcription Factors/metabolism , rho GTP-Binding Proteins/metabolism , Animals , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Humans , Leukotriene B4/immunology , Mice , Mice, Knockout , Microscopy, Confocal , Neutrophils/immunology , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/genetics , Transcription Factors/immunology , rho GTP-Binding Proteins/genetics , rho GTP-Binding Proteins/immunology
12.
J Allergy Clin Immunol ; 123(3): 603-11, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19152965

ABSTRACT

BACKGROUND: Eosinophil differentiation, activation, and survival are largely regulated by IL-5. IL-5-mediated transmembrane signal transduction involves both Lyn-mitogen-activated protein kinases and Janus kinase 2-signal transducer and activator of transcription pathways. OBJECTIVE: We sought to determine whether additional signaling molecules/pathways are critically involved in IL-5-mediated eosinophil survival. METHODS: Eosinophil survival and apoptosis were measured in the presence and absence of IL-5 and defined pharmacologic inhibitors in vitro. The specific role of the serine/threonine kinase proviral integration site for Moloney murine leukemia virus (Pim) 1 was tested by using HIV-transactivator of transcription fusion proteins containing wild-type Pim-1 or a dominant-negative form of Pim-1. The expression of Pim-1 in eosinophils was analyzed by means of immunoblotting and immunofluorescence. RESULTS: Although pharmacologic inhibition of phosphatidylinositol-3 kinase (PI3K) by LY294002, wortmannin, or the selective PI3K p110delta isoform inhibitor IC87114 was successful in each case, only LY294002 blocked increased IL-5-mediated eosinophil survival. This suggested that LY294002 inhibited another kinase that is critically involved in this process in addition to PI3K. Indeed, Pim-1 was rapidly and strongly expressed in eosinophils after IL-5 stimulation in vitro and readily detected in eosinophils under inflammatory conditions in vivo. Moreover, by using specific protein transfer, we identified Pim-1 as a critical element in IL-5-mediated antiapoptotic signaling in eosinophils. CONCLUSIONS: Pim-1, but not PI3K, plays a major role in IL-5-mediated antiapoptotic signaling in eosinophils.


Subject(s)
Apoptosis , Eosinophils/immunology , Interleukin-5/immunology , Phosphatidylinositol 3-Kinases/physiology , Proto-Oncogene Proteins c-pim-1/metabolism , Adenine/analogs & derivatives , Adenine/pharmacology , Androstadienes/pharmacology , Cells, Cultured , Chromones/pharmacology , Eosinophils/drug effects , Eosinophils/enzymology , Humans , Hypersensitivity/enzymology , Hypersensitivity/immunology , Interleukin-5/pharmacology , Janus Kinase 2/immunology , Janus Kinase 2/metabolism , Microscopy, Confocal , Morpholines/pharmacology , Myeloid Cell Leukemia Sequence 1 Protein , Phosphatidylinositol 3-Kinases/immunology , Phosphoinositide-3 Kinase Inhibitors , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-bcl-2/immunology , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins c-pim-1/antagonists & inhibitors , Proto-Oncogene Proteins c-pim-1/immunology , Quinazolines/pharmacology , Tyrphostins/pharmacology , Wortmannin , Xanthenes/pharmacology
13.
Blood ; 113(7): 1526-34, 2009 Feb 12.
Article in English | MEDLINE | ID: mdl-18955562

ABSTRACT

In mice, interleukin-18 (IL-18) regulates Th1- or Th2-type immune responses depending on the cytokine environment and effector cells involved, and the ST2-ligand, IL-33, primarily promotes an allergic phenotype. Human basophils, major players in allergic inflammation, constitutively express IL-18 receptors, while ST2 surface expression is inducible by IL-3. Unexpectedly, freshly isolated basophils are strongly activated by IL-33, but, in contrast to mouse basophils, do not respond to IL-18. IL-33 promotes IL-4, IL-13 and IL-8 secretion in synergy with IL-3 and/or FcepsilonRI-activation, and enhances FcepsilonRI-induced mediator release. These effects are similar to that of IL-3, but the signaling pathways engaged are distinct because IL-33 strongly activates NF-kappaB and shows a preference for p38 MAP-kinase, while IL-3 acts through Jak/Stat and preferentially activates ERK. Eosinophils are the only other leukocyte-type directly activated by IL-33, as evidenced by screening of p38-activation in peripheral blood cells. Only upon CD3/CD28-ligation, IL-33 weakly enhances Th2 cytokine expression by in vivo polarized Th2 cells. This study on primary human cells demonstrates that basophils and eosinophils are the only direct target leukocytes for IL-33, suggesting that IL-33 promotes allergic inflammation and Th2 polarization mainly by the selective activation of these specialized cells of the innate immune system.


Subject(s)
Basophils/immunology , Eosinophils/immunology , Hypersensitivity/immunology , Interleukins/metabolism , Th2 Cells/immunology , Basophils/cytology , CD28 Antigens/metabolism , CD3 Complex/metabolism , Cell Communication/immunology , Cell Membrane/metabolism , Cells, Cultured , Complement C5a/metabolism , Eosinophils/cytology , Humans , Hypersensitivity/metabolism , Hypersensitivity/pathology , Interleukin-1/metabolism , Interleukin-1 Receptor-Like 1 Protein , Interleukin-13/metabolism , Interleukin-18/metabolism , Interleukin-3/metabolism , Interleukin-33 , Interleukin-4/metabolism , Interleukin-8/metabolism , Interleukins/immunology , Leukotriene C4/metabolism , Neutrophils/cytology , Neutrophils/immunology , Receptors, Cell Surface/metabolism , Signal Transduction/immunology , Solubility , Th2 Cells/cytology , Th2 Cells/metabolism
14.
Blood ; 112(10): 3949-58, 2008 Nov 15.
Article in English | MEDLINE | ID: mdl-18768389

ABSTRACT

The contribution of basophils in allergic disease and other Th2-type immune responses depends on their persistence at sites of inflammation, but the ligands and molecular pathways supporting basophil survival are largely unknown. The comparison of rates of apoptosis and of the expression of antiapoptotic proteins in different human granulocyte types revealed that basophils have a considerably longer spontaneous life span than neutrophils and eosinophils consistent with high levels of constitutive Bcl-2 expression. Interleukin-3 (IL-3) is the only ligand that efficiently protects basophils from apoptosis as evidenced by screening a large number of stimuli. IL-3 up-regulates the expression of the antiapoptotic proteins cIAP2, Mcl-1, and Bcl-X(L) and induces a rapid and sustained de novo expression of the serine/threonine kinase Pim1 that closely correlates with cytokine-enhanced survival. Inhibitor studies and protein transduction of primary basophils using wild-type and kinase-dead Pim1-Tat fusion-proteins demonstrate the functional importance of Pim1 induction in the IL-3-enhanced survival. Our data further indicate that the antiapoptotic Pim1-mediated pathway operates independently of PI3-kinase but involves the activation of p38 MAPK. The induction of Pim1 leading to PI3-kinase-independent survival as described here for basophils may also be a relevant antiapoptotic mechanism in other terminally differentiated leukocyte types.


Subject(s)
Apoptosis/physiology , Basophils/metabolism , Gene Expression Regulation, Enzymologic/physiology , Interleukin-3/metabolism , MAP Kinase Signaling System/physiology , Proto-Oncogene Proteins c-pim-1/biosynthesis , Adult , Apoptosis/drug effects , Baculoviral IAP Repeat-Containing 3 Protein , Cell Survival/drug effects , Female , Gene Expression Regulation, Enzymologic/drug effects , Humans , Hypersensitivity/enzymology , Inflammation/enzymology , Inhibitor of Apoptosis Proteins/biosynthesis , Interleukin-3/pharmacology , MAP Kinase Signaling System/drug effects , Male , Myeloid Cell Leukemia Sequence 1 Protein , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Th2 Cells/metabolism , Ubiquitin-Protein Ligases , Up-Regulation/drug effects , Up-Regulation/physiology , bcl-X Protein/biosynthesis , p38 Mitogen-Activated Protein Kinases/metabolism
15.
Blood ; 112(9): 3762-71, 2008 Nov 01.
Article in English | MEDLINE | ID: mdl-18495959

ABSTRACT

The vitamin A metabolite retinoic acid (RA) plays a fundamental role in cellular functions by activating nuclear receptors. Retinaldehyde dehydrogenase-II (RALDH2) creates localized RA gradients needed for proper embryonic development, but very little is known regarding its regulated expression in adults. Using a human ex vivo model of allergic inflammation by coincubating IgE receptor-activated mast cells (MCs) with blood basophils, we observed prominent induction of a protein that was identified as RALDH2 by mass spectroscopy. RALDH2 was selectively induced in basophils by MC-derived interleukin-3 (IL-3) involving PI3-kinase and NF-kappaB pathways. Importantly, neither constitutive nor inducible RALDH2 expression was detectable in any other human myeloid or lymphoid leukocyte, including dendritic cells. RA generated by RALDH2 in basophils modulates IL-3-induced gene expression in an autocrine manner, providing positive (CD25) as well as negative (granzyme B) regulation. It also acts in a paracrine fashion on T-helper cells promoting the expression of CD38 and alpha4/beta7 integrins. Furthermore, RA derived from IL-3-activated basophils provides a novel mechanism of Th2 polarization. Thus, RA must be viewed as a tightly controlled basophil-derived mediator with a high potential for regulating diverse functions of immune and resident cells in allergic diseases and other Th2-type immune responses.


Subject(s)
Basophils/drug effects , Basophils/metabolism , Interleukin-3/pharmacology , Mast Cells/immunology , Retinal Dehydrogenase/biosynthesis , Tretinoin/metabolism , Basophils/immunology , Coculture Techniques , Enzyme Induction/drug effects , Humans , Inflammation Mediators/immunology , Inflammation Mediators/metabolism , Interleukin-3/metabolism , NF-kappa B/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Recombinant Proteins/pharmacology , Signal Transduction/drug effects , Th2 Cells/immunology , Tretinoin/immunology
16.
Med Microbiol Immunol ; 197(4): 369-79, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18283493

ABSTRACT

We present a systematic study that defines molecular profiles of adjuvanticity and pyrogenicity induced by agonists of human Toll-like receptor molecules in vitro. Using P(3)CSK(4), Lipid A and Poly I:C as model adjuvants we show that all three molecules enhance the expansion of IFNgamma(+)/CD4(+) T cells from their naïve precursors following priming with allogeneic DC in vitro. In contrast, co-culture of naive CD4(+) T cells with allogeneic monocytes and TLR2/TLR4 agonists only resulted in enhanced T cell proliferation. Distinct APC molecular signatures in response to each TLR agonist underline the dual effect observed on T cell responses. Using protein and gene expression assays, we show that TNF-alpha and CXCL10 represent DC-restricted molecular signatures of TLR2/TLR4 and TLR3 activation, respectively, in sharp contrast to IL-6 produced by monocytes upon stimulation with P(3)CSK(4) and Lipid A. Furthermore, although all TLR agonists are able to up-regulate proIL-1beta specific gene in both cell types, only monocyte activation with Lipid A results in detectable IL-1beta release. These molecular profiles, provide a simple screen to select new immune enhancers of human Th1 responses suitable for clinical application.


Subject(s)
Adjuvants, Immunologic/pharmacology , Dendritic Cells/immunology , Lymphocyte Activation , Monocytes/immunology , Toll-Like Receptors/agonists , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Cell Proliferation , Cells, Cultured , Chemokine CXCL10/immunology , Chemokine CXCL10/metabolism , Dendritic Cells/metabolism , Gene Expression Profiling , Humans , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-1beta/immunology , Interleukin-1beta/metabolism , Interleukin-6/immunology , Interleukin-6/metabolism , Lipid A/immunology , Lipid A/pharmacology , Monocytes/metabolism , Poly I-C/immunology , Poly I-C/pharmacology , Toll-Like Receptors/immunology , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
17.
Pediatr Res ; 61(4): 462-6, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17515872

ABSTRACT

Maternal smoking in pregnancy is associated with respiratory diseases in the offspring, possibly due to prenatal influences on the developing immune system. We investigated whether maternal smoking in pregnancy was associated with cord blood leukocyte numbers, including precursor dendritic cells, adjusting for concomitant factors. In a prospective healthy birth cohort study, total leukocyte counts were reduced in neonates of smoking mothers [10.7 (8.4-13.0), n=14] compared with nonexposed infants [14.7 (13.7-15.7), n=74, p=0.002] [geometric mean cells x 10(3)/microL (95% confidence interval)]. All leukocyte subsets were decreased, most prominently segmented neutrophils [4.3 (2.8-5.7) versus 6.2 (5.5-6.8), p=0.021], lymphocytes [3.8 (2.9-4.8) versus 5.0 (4.5-5.6), p=0.036], and myeloid precursor dendritic cells [12.7 cells/microL (9.1-17.8) versus 18.3 (15.8-21.2), p=0.055]. These differences persisted after adjustment for possible confounders. Predictors of myeloid precursor dendritic cell numbers in multivariable models were maternal smoking (-5.1 cells/microL, p=0.042), age (-0.5 cells/microL/y, p=0.035), and, marginally, asthma (+8.1 cells/microL, p=0.075). The decrease of all leukocytes in neonates of smoking mothers could be clinically significant and suggests a decreased cell production, increased peripheral recruitment, or retention in bone marrow. Given the importance of dendritic cells in early immune responses, their decrease might reflect an impact of maternal smoking on the developing fetal immune system.


Subject(s)
Dendritic Cells/drug effects , Leukocytes/drug effects , Prenatal Exposure Delayed Effects/etiology , Smoking/adverse effects , Cell Count , Cohort Studies , Dendritic Cells/cytology , Female , Humans , Infant, Newborn , Leukocytes/cytology , Leukopenia/etiology , Male , Pregnancy , Prospective Studies
18.
Blood ; 108(7): 2290-9, 2006 Oct 01.
Article in English | MEDLINE | ID: mdl-16794249

ABSTRACT

Histamine, leukotriene C4, IL-4, and IL-13 are major mediators of allergy and asthma. They are all formed by basophils and are released in particularly large quantities after stimulation with IL-3. Here we show that supernatants of activated mast cells or IL-3 qualitatively change the makeup of granules of human basophils by inducing de novo synthesis of granzyme B (GzmB), without induction of other granule proteins expressed by cytotoxic lymphocytes (granzyme A, perforin). This bioactivity of IL-3 is not shared by other cytokines known to regulate the function of basophils or lymphocytes. The IL-3 effect is restricted to basophil granulocytes as no constitutive or inducible expression of GzmB is detected in eosinophils or neutrophils. GzmB is induced within 6 to 24 hours, sorted into the granule compartment, and released by exocytosis upon IgE-dependent and -independent activation. In vitro, there is a close parallelism between GzmB, IL-13, and leukotriene C4 production. In vivo, granzyme B, but not the lymphoid granule marker granzyme A, is released 18 hours after allergen challenge of asthmatic patients in strong correlation with interleukin-13. Our study demonstrates an unexpected plasticity of the granule composition of mature basophils and suggests a role of granzyme B as a novel mediator of allergic diseases.


Subject(s)
Asthma/blood , Basophils/metabolism , Serine Endopeptidases/physiology , Antibodies, Monoclonal/chemistry , Asthma/metabolism , Bronchoalveolar Lavage , Complement C5a/chemistry , Granzymes , Humans , Inflammation , Interleukin-13/metabolism , Interleukin-3/metabolism , Killer Cells, Natural/metabolism , Leukotriene C4/metabolism , Mast Cells/cytology , Serine Endopeptidases/metabolism , T-Lymphocytes, Cytotoxic/metabolism
19.
Shock ; 22(6): 513-20, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15545821

ABSTRACT

Several CXC-chemokines, of which interleukin (IL)-8 is the prototype, are potent neutrophil chemotactic and activating cytokines, inducing the secretion of granule proteins and the generation of reactive oxygen intermediates that may cause tissue damage and amplify inflammatory responses. Here, we investigated whether chemokines play a key role in the inflammatory process following cardiac surgery with cardiopulmonary bypass (CPB) in children. We performed an observational prospective clinical study of 40 pediatric patients before, during, and after open heart surgery with CPB. Plasma levels of chemokines, myeloperoxidase (MPO), and lactoferrin were measured by immunoassays. Cell surface receptors were detected by flow cytometry. Plasma levels of IL-8 were increased after CPB, correlating strongly with a reduction of expression of the CXC-chemokine receptors (CXCR) 1 and 2 on neutrophils indicating in vivo activation of neutrophils by IL-8. Other CXC-chemokines with Glu-Leu-Arg motif showed no correlation with CXCR1 or CXCR2 expression. Two components of neutrophilic granules, MPO and lactoferrin, were strongly elevated postoperatively, and the levels of both were correlated with IL-8. Levels of monocyte chemoattractant protein (MCP)-1 were increased postoperatively, correlating with a reduction of CCR2 expression and an increase of CD11b expression on monocytes, suggesting monocyte activation by MCP-1. The early postoperative course was complicated in patients with an increase of these inflammatory parameters. Impaired cardiovascular function correlated with increased levels of IL-8 and activation of neutrophils and was most prominent in patients with a long time on CPB and in those with cyanotic heart lesions. In conclusion, MCP-1 is involved in the regulation of chemotaxis and function of monocytes during and early after the end of CPB. Activation of neutrophils and down-regulation of CXCR1 and CXCR2 were predominantly caused by IL-8. This activation implies release of components of neutrophilic granules and correlates with the need for inotropic support.


Subject(s)
Chemokines, CXC/pharmacology , Lactoferrin/blood , Neutrophils/drug effects , Peroxidase/blood , Thoracic Surgery , Chemokine CCL2/analysis , Chemokine CCL2/metabolism , Child , Child, Preschool , Down-Regulation , Heart Defects, Congenital , Humans , Infant , Interleukin-8/blood , Lactic Acid/blood , Postoperative Care , Receptors, Interleukin-8A/analysis , Receptors, Interleukin-8A/metabolism , Receptors, Interleukin-8B/analysis , Receptors, Interleukin-8B/metabolism , Treatment Outcome
20.
Blood ; 103(11): 4195-7, 2004 Jun 01.
Article in English | MEDLINE | ID: mdl-14982879

ABSTRACT

Thrombotic thrombocytopenic purpura (TTP) either occurs in a congenital form caused by ADAMTS13 gene mutations or it is acquired and most often due to ADAMTS13 inhibitory autoantibodies. In congenital TTP siblings are often affected, while acquired TTP occurs sporadically and familial clustering has not been described so far. We report identical twin sisters suffering from acquired TTP due to immunoglobulin G (IgG) autoantibodies inactivating ADAMTS13, suggesting an important role of hitherto unidentified genetic determinants of ADAMTS13 inhibitor formation. These cases also demonstrate that familial clustering is not sufficient for unambiguously diagnosing hereditary ADAMTS13 deficiency and congenital TTP.


Subject(s)
Metalloendopeptidases/genetics , Metalloendopeptidases/immunology , Purpura, Thrombotic Thrombocytopenic/genetics , Purpura, Thrombotic Thrombocytopenic/immunology , ADAM Proteins , ADAMTS13 Protein , Adult , Autoantibodies/blood , Female , Histocompatibility Testing , Humans , Metalloendopeptidases/deficiency , Twins, Monozygotic/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...